Denmark Chemicals

Novozymes A/S (NSIS-B)

Track

Novozymes A/S experienced varied insider trading activity, with the most recent transaction occurring on May 6, 2026. Board members and executives engaged in both acquisitions and disposals of equity throughout the observed period. These movements reflect diverse individual financial decisions rather than a singular trend among leadership regarding the company's long-term outlook.
Ticker: NSIS-B Exchange: CPH
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Novozymes A/S. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
2.7
Heine Dalsgaard Vice Chair of the Board Director
Transaction date
Purchase
Price
415.85
Quantity 41,425
Value DKK1,487,745
0.9
Claus Crone Fuglsang Executive Vice President, Chief Scientific Officer Officer
Transaction date
Sale
Price
166.19
Quantity 55,360
Value DKK3,739,774
3.2
Morten Enggaard Rasmussen Executive Vice President, People & Stakeholder Relations Officer
Transaction date
Purchase
Price
309.13
Quantity 37,003
Value DKK662,835
3.2
Morten Enggaard Rasmussen Executive Vice President, People & Stakeholder Relations Officer
Transaction date
Purchase
Price
347.40
Quantity 725
Value DKK251,865
2.9
Kevin Lane Member of the Board Director
Transaction date
Purchase
Price
368.10
Quantity 1,500
Value DKK552,150
2.7
Heine Dalsgaard Vice Chair of the Board Director
Transaction date
Purchase
Price
371.98
Quantity 2,700
Value DKK1,004,347
2.7
Heine Dalsgaard Vice Chair of the Board Director
Transaction date
Purchase
Price
397.07
Quantity 2,500
Value DKK992,679
3.2
Morten Enggaard Rasmussen Executive Vice President of People & Stakeholder Relations Officer
Transaction date
Purchase
Price
418.10
Quantity 380
Value DKK158,878
2.2
Tina Sejersgård Fanø Executive Vice President, Planetary Health Biosolutions Officer
Transaction date
Sale
Price
405.46
Quantity 48,610
Value DKK19,709,251
3.6
Rainer Lehmann CFO & Executive Vice President Officer
Transaction date
Purchase
Price
396.23
Quantity 2,000
Value DKK792,458
2.7
Heine Dalsgaard Vice Chair of the Board of Directors Executive Director
Transaction date
Purchase
Price
398.49
Quantity 3,000
Value DKK1,195,470
3.2
Morten Enggaard Rasmussen Executive Vice President of People & Stakeholder Relations Officer
Transaction date
Purchase
Price
390.00
Quantity 716
Value DKK279,240
3.6
Rainer Lehmann CFO & Executive Vice President Officer
Transaction date
Purchase
Price
396.23
Quantity 2,000
Value DKK792,458
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-05-06 2026-05-06 B Purchase
2.7
Heine Dalsgaard

Vice Chair of the Board

Director
41,425
415.85
DKK1,487,745 		41,425 415.85 DKK1,487,745
2026-03-26 2026-03-25 S Sale
0.9
Claus Crone Fuglsang

Executive Vice President, Chief Scientific Officer

Officer
55,360
166.19
DKK3,739,774 		55,360 166.19 DKK3,739,774
2026-03-23 2026-03-19 B Purchase
3.2
Morten Enggaard Rasmussen

Executive Vice President, People & Stakeholder Relations

Officer
37,003
309.13
DKK662,835 		37,003 309.13 DKK662,835
2026-03-11 2026-03-11 B Purchase
3.2
Morten Enggaard Rasmussen

Executive Vice President, People & Stakeholder Relations

Officer
725
347.40
DKK251,865 		725 347.40 DKK251,865
2026-02-27 2026-02-26 B Purchase
2.9
Kevin Lane

Member of the Board

Director
1,500
368.10
DKK552,150 		1,500 368.10 DKK552,150
2026-02-26 2026-02-26 B Purchase
2.7
Heine Dalsgaard

Vice Chair of the Board

Director
2,700
371.98
DKK1,004,347 		2,700 371.98 DKK1,004,347
2025-11-21 2025-11-20 B Purchase
2.7
Heine Dalsgaard

Vice Chair of the Board

Director
2,500
397.07
DKK992,679 		2,500 397.07 DKK992,679
2025-11-07 2025-11-07 B Purchase
3.2
Morten Enggaard Rasmussen

Executive Vice President of People & Stakeholder Relations

Officer
380
418.10
DKK158,878 		380 418.10 DKK158,878
2025-09-02 2025-09-01 S Sale
2.2
Tina Sejersgård Fanø

Executive Vice President, Planetary Health Biosolutions

Officer
48,610
405.46
DKK19,709,251 		48,610 405.46 DKK19,709,251
2025-08-28 2025-08-25 B Purchase
3.6
Rainer Lehmann

CFO & Executive Vice President

Officer
2,000
396.23
DKK792,458 		2,000 396.23 DKK792,458
2025-08-22 2025-08-22 B Purchase
2.7
Heine Dalsgaard

Vice Chair of the Board of Directors

Executive Director
3,000
398.49
DKK1,195,470 		3,000 398.49 DKK1,195,470
2025-08-22 2025-08-22 B Purchase
3.2
Morten Enggaard Rasmussen

Executive Vice President of People & Stakeholder Relations

Officer
716
390.00
DKK279,240 		716 390.00 DKK279,240
2025-08-28 2025-02-25 B Purchase
3.6
Rainer Lehmann

CFO & Executive Vice President

Officer
2,000
396.23
DKK792,458 		2,000 396.23 DKK792,458
Explore more

More insider trading research around Novozymes A/S

More insider trades in Denmark
Similar Basic Materials companies with insider activity
More Chemicals companies with insider activity
More Chemicals companies with insider activity
Insider trading in Europe
Insider trades in Europe Stoxx 600